Effects of PK 8165, a partial benzodiazepine receptor agonist, on cholecystokinin-induced activation of hippocampal pyramidal neurons: a microiontophoretic study in the rat.

[1]  C. Montigny,et al.  Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones , 1984, Nature.

[2]  G. Fur,et al.  Biochemical evidence that 2-phenyl-4[2-(4-piperidinyl) ethyl]quinoline, a quinoline derivative with pure anticonflict properties, is a partial agonist of benzodiazepine receptors , 1984, Neuropharmacology.

[3]  S. File,et al.  Behavioural effects of PK 8165 that are not mediated by benzodiazepine binding sites , 1984, Neuroscience Letters.

[4]  J. Simiand,et al.  The quinolines PK 8165 and PK 9084 possess benzodiazepine-like activity in vitro but not in vivo , 1984, Neuroscience Letters.

[5]  H. Yamamura,et al.  PK 8165 and PK 9084, two quinoline derivatives with anxiolytic properties, antagonize the anticonvulsant effects of diazepam , 1983, Brain Research.

[6]  B. Beer,et al.  Molecular substrates of anxiety: clues from the heterogeneity of benzodiazepine receptors. , 1982, Life sciences.

[7]  M. Morelli,et al.  The effect of GABA on in vitro binding of two novel non-benzodiazepines, PK 8165 and CGS 8216, to benzodiazepine receptors in the rat brain. , 1982, Life sciences.

[8]  L. Pieri,et al.  Selective antagonists of benzodiazepines , 1981, Nature.

[9]  M. Héaulme,et al.  Multiple benzodiazepine receptors: evidence of dissociation between anticonflict and anticonvulsant properties by PK 8165 and PK 9084 (two quinoline derivatives). , 1981, Life sciences.

[10]  J. Kelly,et al.  The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus , 1981, Brain Research.

[11]  E. Pimentel,et al.  Accumulation of Excessive Doses of Iodide by the Thyroid Gland of Normal, Hypophysectomized and Thyroxine-treated Rats , 1966, Nature.